JPRN-UMIN000003855已完成2 期
Phase II study of cisplatin, pemetrexed plus bevacizumab for EGFR mutation negative or unknown stage III/IV non-small-cell lung cancer (non-squamous cell lung cancer) - Phase II study of CDDP/PEM/BEV for EGFR mutation negative stage III/IV non-small-cell lung cancer)
Departmnent of Thoracic Oncology Kanagawa Cancer Center0 个研究点目标入组 25 人开始时间: 2010年7月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Massive pleural effusion 2)Massive pericardial effusion 3)Double cancer 4)Severe complications; myocardial infarction, unstable angina, heart failure, uncontrolled hypertension, and unconrolled diabetis mellitus, uncontrolled infection, uncontrolled mental disease, SVC syndrome 5)Hemoptysis(more than 2.5ml), continuous or treatment-required bloody sputum 6)Invasion to large vessels, cavity in tumor 7)Brain metastsis 8)Under anti-coagulation therapy 9)Bleeding 10)Nephrosis 11)Uncured wound 12)Digestive tract ulcer, diverticulosis 13)Bone marrow suppression 14)Lung fibrosis 15)Pregnancy 16)Other inappropriate cases
研究者
相似试验
已完成
2 期
A phase II study of Cisplatin+Pemetrexed +Bevacizumab for gefitinib refractory NSCLC patients with mutated EGFRon-small cell lung cancer(Non squamous)JPRN-UMIN000012215iigata Lung Cancer Treatment Group28
已完成
不适用
A Phase II Study of Cisplatin, Pemetrexed and Bevacizumab for Advanced Non-Small Cell (Non squamous cell) Lung CancerAdvanced Non-Small Cell (Non squamous cell) Lung CanceJPRN-UMIN000005763Japanese Foundation for Cancer Research, the Cancer Institute Hospital45
已完成
2 期
A phase 2 study of cisplatin/pemetrexed followed by maintenance pemetrexed in patients with stage 3B or 4 non-squamous non-small-cell lung cancer.Previously untreated stageIIIB/IV non-squamous non-small-cell lung cancerJPRN-UMIN000002686Kinki-chuo chest medical center35
进行中（未招募）
不适用
Phase I/II study with cisplatin and pemetrexed +/- sorafenib in malignant pleural mesothelioma (SoMe study) - SoMe Studymalignant pleural mesothelioma (MPM)MedDRA version: 9.1Level: LLTClassification code 10059518Term: Pleural mesothelioma malignantEUCTR2007-005894-77-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
已完成
2 期
Phase II study of Pemetrexed and Cisplatin plus Bevacizumab with Maintenance Pemetrexed as First-Line Therapy for Nonsquamous Non-small-cell Lung Cancer (ALCT001)onsquamous Non-small-cell Lung CancerJPRN-UMIN000010804Kyorin Univercity Hospital25